🇦🇺

Pfizer, BioNTech get vaccine 'fast track' from FDA

Video Credit: Reuters - Politics
Published on July 13, 2020 - Duration: 01:02s

Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration, speeding up the regulatory review process.

Jillian Kitchener has more.

Advertisement

Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer and its German partner BioNTech on Monday announced two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration.

...meaning the FDA may decide on an approval within six months.

If a vaccine candidate gets the green light, the companies said they expect to make up to 100 million doses by the end of this year.

The companies said the recent testing of an experimental vaccine on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people.

Upon regulatory approval, the companies expect to start a large trial with up to 30,000 participants… possibly later this month - paving the way toward a potential release of a vaccine.

The U.S. and other countries have poured billions into developing a safe and effective vaccine for COVID-19.

As of now - none are approved.

You are here


💡 One News Page Knowledge: Other News Mentions



Related videos from verified sources

UK Orders 90 Million COVID-19 Vaccine Doses from Pfizer and Valneva 01:07
Video credit: Wibbitz Top Stories - Published on July 21, 2020 

Pfizer-BioNTech vaccine shows promise 00:48
Video credit: Reuters Studio - Published on July 20, 2020 

Britain signs vaccine deals for 90mln doses 01:24
Video credit: Reuters Studio - Published on July 20, 2020 

You might like